{"nct_id":"NCT00697853","title":"Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults","status":"COMPLETED","status_verified_date":"2008-06","start_date":"1998-11","start_date_type":null,"primary_completion_date":"1999-07","primary_completion_date_type":"ACTUAL","completion_date":null,"completion_date_type":null,"phases":["PHASE2"],"tickers":["GSK"]}